Skip to main content

Aureobasidium pullulans

NDC 22840-5607 · Greer Laboratories, Inc.

Generic nameAureobasidium pullulans
Dosage formSOLUTION
RouteINTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Active ingredient(s)AUREOBASIDIUM PULLULANS VAR. PULLUTANS
Strength.025 g/mL
Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]
Marketing categoryBLA

Packages

22840-5607-2 — 10 mL in 1 VIAL, MULTI-DOSE (22840-5607-2)

22840-5607-4 — 50 mL in 1 VIAL, MULTI-DOSE (22840-5607-4)

22840-5607-5 — 5 mL in 1 BOTTLE, DROPPER (22840-5607-5)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0268-8086 — AUREOBASIDIUM PULLULANS VAR. PULLUTANS, 0268-8087 — AUREOBASIDIUM PULLULANS VAR. PULLUTANS, 22840-1630 — Aureobasidium pullulans, 22840-9607 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9608 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9609 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9610 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9612 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9613 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 49643-117 — Pullularia pullulans, 65044-5233 — Pullularia pullulans, 65044-5235 — Pullularia pullulans

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels